The objectives of this study are to increase families' understanding of eczema and improve eczema management in the primary care setting. The investigators plan to create an educational video for families providing general information about eczema as well as instructions about good skincare management and common treatments. The investigators will conduct a randomized controlled trial of the plan in the primary care clinic at Boston Children's Hospital. Specifically, the investigators aim to (1) decrease eczema severity (2) improve patient and family quality of life (QOL) and (3) increase parental knowledge about eczema and eczema management.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
168
Video with information about eczema and eczema treatment, to be watched in clinic and at home
Video with information about eczema and eczema treatment, to be watched at home only
change in eczema severity
eczema severity as measured by the Patient Oriented Eczema Measure (0-28 range, higher score=worse eczema severity)
Time frame: 3 month follow-up
change in infant quality of life
infant quality of life as measured by the IDQOL (Infant's Dermatitis Quality of Life Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children \<4 years of age.
Time frame: 3 month follow-up
change in family quality of life
family quality of life as measured by the DFI (Dermatitis Family Impact Questionnaire), 0-30 scale with higher score reflecting worse quality of life
Time frame: 3 month follow-up
change in caregiver knowledge
change in caregiver knowledge pre-post as assessed by a questionnaire. This is not a standardized tool, but rather a series of 22 questions about caregiver comfort and understanding of eczema. Some responses use a likert scale format, while others are multiple choice questions. There are 8 multiple choice questions, each of which has one right answer. Those can be totaled to determine percentage correct.
Time frame: 3 month follow-up
change in child quality of life
child quality of life as measured by the CDLQI (Children's Dermatology Life Quality Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children age 4-16.
Time frame: 3 month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.